The Study of New RIC Regimen of BuFlu in Older or Intolerable Patients With Hematologic Malignant Diseases

Trial Profile

The Study of New RIC Regimen of BuFlu in Older or Intolerable Patients With Hematologic Malignant Diseases

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2013

At a glance

  • Drugs Busulfan (Primary) ; Fludarabine (Primary) ; Cytarabine; Hydroxycarbamide; Semustine
  • Indications Haematological malignancies
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top